100 ML eptifibatide 0.75 MG/ML Injection

Known as: EPTIFIBATIDE 0.75MG/ML INJ, EPTIFIBATIDE 0.75 mg in 1 mL INTRAVENOUS INJECTION, SOLUTION, EPTIFIBATIDE 0.75MG/ML INJ [VA Product] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2010
012320042010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND/AIMS Eptifibatide is a parenteral glycoprotein IIb-IIIa inhibitor that prevents platelet aggregation. Although… (More)
Is this relevant?
2004
2004
Clinically used GPIIb/IIIa blockers are ligand mimetics, and thereby their binding can induce conformational changes of the… (More)
Is this relevant?
2004
2004
Clinically used GPIIb/IIIa blockers are ligand mimetics, and thereby their binding can induce conformational changes of the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?